3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Valvular Heart Disease
Valvular heart disease occurs when one or more of the heart's valves are damaged, affecting the normal flow of blood through the heart. This condition can involve valve stenosis (narrowing of the valve opening) or valve regurgitation (leakage of the valve), both of which can impair heart function over time. Common causes include age-related changes, infections like endocarditis, or congenital defects. Symptoms of valvular heart disease may include fatigue, shortness of breath, and swelling in the legs. Treatment options vary based on the severity of the condition and may include medications to control symptoms or surgical interventions such as valve repair or replacement. Early detection and management are key to preventing more severe complications.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain